Accuray Incorporated (ARAY) earnings
ARAY earnings moved a median of -4.53% by the close. Quarterly and annual ARAY reports and results, each read against the price at its own news timestamp. Back to the ARAY overview →
16 measured ARAY earnings events.
Where these ARAY earnings landedvs 16 measured ARAY earnings reactions
| Middle 50% of ARAY earnings reactions | -8.46% to +0.61% |
|---|---|
| Median reaction (to close) | -4.53% |
| Measured reactions | 16 |
Point-in-time · zero look-ahead
Half of the 16 ARAY earnings events with a measured close landed between -8.46% and +0.61%; 25% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-K ACCURAY INC For: Jun 30 | SEC filing · Form 10-K | +1.61% | +4.94% | |
| Form 10-Q ACCURAY INC For: Mar 31 | SEC filing · Form 10-Q | +1.57% | -17.62% | |
| Form 10-K/A ACCURAY INC For: Jun 30 | SEC filing · Form 10-K | -0.94% | -8.46% | |
| Form 10-Q ACCURAY INC For: Dec 31 | SEC filing · Form 10-Q | -0.94% | -8.46% | |
| Form 10-Q/A ACCURAY INC For: Sep 30 | SEC filing · Form 10-Q | -0.94% | -8.46% | |
| Form NT 10-Q ACCURAY INC For: Dec 31 | SEC filing · Form NT | +1.88% | -2.65% | |
| Form 10-Q ACCURAY INC For: Sep 30 | SEC filing · Form 10-Q | +1.56% | -4.69% | |
| Form 10-K ACCURAY INC For: Jun 30 | SEC filing · Form 10-K | +0.00% | -2.56% | |
| Form 10-Q ACCURAY INC For: Mar 31 | SEC filing · Form 10-Q | -3.65% | -4.38% | |
| Form 10-Q ACCURAY INC For: Dec 31 | SEC filing · Form 10-Q | +9.23% | +3.46% | |
| Form 10-Q ACCURAY INC For: Sep 30 | SEC filing · Form 10-Q | -2.63% | +10.00% | |
| Form 10-K ACCURAY INC For: Jun 30 | SEC filing · Form 10-K | -3.95% | -8.95% | |
| Form NT 10-K ACCURAY INC For: Jun 30 | SEC filing · Form NT | -5.63% | -10.80% | |
| Form 10-Q ACCURAY INC For: Mar 31 | SEC filing · Form 10-Q | +4.24% | +2.42% | |
| Form 10-Q ACCURAY INC For: Dec 31 | SEC filing · Form 10-Q | -1.61% | +0.00% | |
| Form 10-Q ACCURAY INC For: Sep 30 | SEC filing · Form 10-Q | -4.04% | -7.32% |
Keep exploring
More ARAY: analyst actions → · SEC filings → · ARAY overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| CRISPR Therapeutics AG - Common Shares (CRSP) | 291 | +0.10% | 53% |
| Seres Therapeutics, Inc. (MCRB) | 290 | -0.23% | 46% |
| Chemed Corp (CHE) | 288 | +0.02% | 53% |
| Fate Therapeutics, Inc. (FATE) | 287 | -0.76% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.